aluates Reports

$ 0.0

Automative

Global LFA-based Cardiac Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-32I9043

Global LFA based Cardiac Market Size Status and Forecast 2022

BUY CHAPTERS

Global LFA-based Cardiac Market Research Report 2024

Code: QYRE-Auto-32I9043

Report

February 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Abbott

Danaher

Bio Rad Laboratories

bioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox Laboratories

Wondfo Biotech

Siemens AG

LFA-based Cardiac Market Size

The global LFA-based Cardiac market was valued at US$ 3595.4 million in 2023 and is anticipated to reach US$ 6160.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.

LFA-based Cardiac Market

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.

This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.

Report Scope

The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of LFA-based Cardiac Market Report

Report Metric	Details
Report Name	LFA-based Cardiac Market
Accounted market size in 2023	US$ 3595.4 million
Forecasted market size in 2030	US$ 6160.2 million
CAGR	7.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Troponin I Troponin T CK-MB Myoglobin Others
Segment by Application	Laboratory Testing Point-of-care Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, Wondfo Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is LFA-based Cardiac Market growing?

Ans: The LFA-based Cardiac Market witnessing a CAGR of 7.9% during the forecast period 2024-2030.

What is the LFA-based Cardiac Market size in 2030?

Ans: The LFA-based Cardiac Market size in 2030 will be US$ 6160.2 million.

What is the Roche share in LFA-based Cardiac Market?

Ans: The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.

Who are the main players in the LFA-based Cardiac Market report?

Ans: The main players in the LFA-based Cardiac Market are Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, Wondfo Biotech

What are the Application segmentation covered in the LFA-based Cardiac Market report?

Ans: The Applications covered in the LFA-based Cardiac Market report are Laboratory Testing, Point-of-care Testing

What are the Type segmentation covered in the LFA-based Cardiac Market report?

Ans: The Types covered in the LFA-based Cardiac Market report are Troponin I, Troponin T, CK-MB, Myoglobin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Troponin I

1.2.3 Troponin T

1.2.4 CK-MB

1.2.5 Myoglobin

1.2.6 Others

1.3 Market by Application

1.3.1 Global LFA-based Cardiac Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Laboratory Testing

1.3.3 Point-of-care Testing

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global LFA-based Cardiac Market Perspective (2019-2030)

2.2 LFA-based Cardiac Growth Trends by Region

2.2.1 Global LFA-based Cardiac Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 LFA-based Cardiac Historic Market Size by Region (2019-2024)

2.2.3 LFA-based Cardiac Forecasted Market Size by Region (2025-2030)

2.3 LFA-based Cardiac Market Dynamics

2.3.1 LFA-based Cardiac Industry Trends

2.3.2 LFA-based Cardiac Market Drivers

2.3.3 LFA-based Cardiac Market Challenges

2.3.4 LFA-based Cardiac Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top LFA-based Cardiac Players by Revenue

3.1.1 Global Top LFA-based Cardiac Players by Revenue (2019-2024)

3.1.2 Global LFA-based Cardiac Revenue Market Share by Players (2019-2024)

3.2 Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by LFA-based Cardiac Revenue

3.4 Global LFA-based Cardiac Market Concentration Ratio

3.4.1 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Revenue in 2023

3.5 LFA-based Cardiac Key Players Head office and Area Served

3.6 Key Players LFA-based Cardiac Product Solution and Service

3.7 Date of Enter into LFA-based Cardiac Market

3.8 Mergers & Acquisitions, Expansion Plans

4 LFA-based Cardiac Breakdown Data by Type

4.1 Global LFA-based Cardiac Historic Market Size by Type (2019-2024)

4.2 Global LFA-based Cardiac Forecasted Market Size by Type (2025-2030)

5 LFA-based Cardiac Breakdown Data by Application

5.1 Global LFA-based Cardiac Historic Market Size by Application (2019-2024)

5.2 Global LFA-based Cardiac Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America LFA-based Cardiac Market Size (2019-2030)

6.2 North America LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America LFA-based Cardiac Market Size by Country (2019-2024)

6.4 North America LFA-based Cardiac Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe LFA-based Cardiac Market Size (2019-2030)

7.2 Europe LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe LFA-based Cardiac Market Size by Country (2019-2024)

7.4 Europe LFA-based Cardiac Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific LFA-based Cardiac Market Size (2019-2030)

8.2 Asia-Pacific LFA-based Cardiac Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific LFA-based Cardiac Market Size by Region (2019-2024)

8.4 Asia-Pacific LFA-based Cardiac Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America LFA-based Cardiac Market Size (2019-2030)

9.2 Latin America LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America LFA-based Cardiac Market Size by Country (2019-2024)

9.4 Latin America LFA-based Cardiac Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa LFA-based Cardiac Market Size (2019-2030)

10.2 Middle East & Africa LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa LFA-based Cardiac Market Size by Country (2019-2024)

10.4 Middle East & Africa LFA-based Cardiac Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche LFA-based Cardiac Introduction

11.1.4 Roche Revenue in LFA-based Cardiac Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott LFA-based Cardiac Introduction

11.2.4 Abbott Revenue in LFA-based Cardiac Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Siemens

11.3.1 Siemens Company Detail

11.3.2 Siemens Business Overview

11.3.3 Siemens LFA-based Cardiac Introduction

11.3.4 Siemens Revenue in LFA-based Cardiac Business (2019-2024)

11.3.5 Siemens Recent Development

11.4 Danaher

11.4.1 Danaher Company Detail

11.4.2 Danaher Business Overview

11.4.3 Danaher LFA-based Cardiac Introduction

11.4.4 Danaher Revenue in LFA-based Cardiac Business (2019-2024)

11.4.5 Danaher Recent Development

11.5 Bio-Rad Laboratories

11.5.1 Bio-Rad Laboratories Company Detail

11.5.2 Bio-Rad Laboratories Business Overview

11.5.3 Bio-Rad Laboratories LFA-based Cardiac Introduction

11.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2019-2024)

11.5.5 Bio-Rad Laboratories Recent Development

11.6 BioMérieux

11.6.1 BioMérieux Company Detail

11.6.2 BioMérieux Business Overview

11.6.3 BioMérieux LFA-based Cardiac Introduction

11.6.4 BioMérieux Revenue in LFA-based Cardiac Business (2019-2024)

11.6.5 BioMérieux Recent Development

11.7 Thermo Fisher

11.7.1 Thermo Fisher Company Detail

11.7.2 Thermo Fisher Business Overview

11.7.3 Thermo Fisher LFA-based Cardiac Introduction

11.7.4 Thermo Fisher Revenue in LFA-based Cardiac Business (2019-2024)

11.7.5 Thermo Fisher Recent Development

11.8 Ortho Clinical Diagnostics

11.8.1 Ortho Clinical Diagnostics Company Detail

11.8.2 Ortho Clinical Diagnostics Business Overview

11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Introduction

11.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2019-2024)

11.8.5 Ortho Clinical Diagnostics Recent Development

11.9 LSI Medience Corporation

11.9.1 LSI Medience Corporation Company Detail

11.9.2 LSI Medience Corporation Business Overview

11.9.3 LSI Medience Corporation LFA-based Cardiac Introduction

11.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Business (2019-2024)

11.9.5 LSI Medience Corporation Recent Development

11.10 Randox laboratories

11.10.1 Randox laboratories Company Detail

11.10.2 Randox laboratories Business Overview

11.10.3 Randox laboratories LFA-based Cardiac Introduction

11.10.4 Randox laboratories Revenue in LFA-based Cardiac Business (2019-2024)

11.10.5 Randox laboratories Recent Development

11.11 Wondfo Biotech

11.11.1 Wondfo Biotech Company Detail

11.11.2 Wondfo Biotech Business Overview

11.11.3 Wondfo Biotech LFA-based Cardiac Introduction

11.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Business (2019-2024)

11.11.5 Wondfo Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Abbott

Danaher

Bio Rad Laboratories

bioMérieux

Thermo Fisher

Ortho Clinical Diagnostics

LSI Medience Corporation

Randox Laboratories

Wondfo Biotech

Siemens AG

List of Tables

Table 1. Global LFA-based Cardiac Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Troponin I

Table 3. Key Players of Troponin T

Table 4. Key Players of CK-MB

Table 5. Key Players of Myoglobin

Table 6. Key Players of Others

Table 7. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global LFA-based Cardiac Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global LFA-based Cardiac Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global LFA-based Cardiac Market Share by Region (2019-2024)

Table 11. Global LFA-based Cardiac Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global LFA-based Cardiac Market Share by Region (2025-2030)

Table 13. LFA-based Cardiac Market Trends

Table 14. LFA-based Cardiac Market Drivers

Table 15. LFA-based Cardiac Market Challenges

Table 16. LFA-based Cardiac Market Restraints

Table 17. Global LFA-based Cardiac Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global LFA-based Cardiac Market Share by Players (2019-2024)

Table 19. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2023)

Table 20. Ranking of Global Top LFA-based Cardiac Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by LFA-based Cardiac Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players LFA-based Cardiac Product Solution and Service

Table 24. Date of Enter into LFA-based Cardiac Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global LFA-based Cardiac Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global LFA-based Cardiac Revenue Market Share by Type (2019-2024)

Table 28. Global LFA-based Cardiac Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global LFA-based Cardiac Revenue Market Share by Type (2025-2030)

Table 30. Global LFA-based Cardiac Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global LFA-based Cardiac Revenue Market Share by Application (2019-2024)

Table 32. Global LFA-based Cardiac Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global LFA-based Cardiac Revenue Market Share by Application (2025-2030)

Table 34. North America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific LFA-based Cardiac Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific LFA-based Cardiac Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific LFA-based Cardiac Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)

Table 49. Roche Company Detail

Table 50. Roche Business Overview

Table 51. Roche LFA-based Cardiac Product

Table 52. Roche Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 53. Roche Recent Development

Table 54. Abbott Company Detail

Table 55. Abbott Business Overview

Table 56. Abbott LFA-based Cardiac Product

Table 57. Abbott Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 58. Abbott Recent Development

Table 59. Siemens Company Detail

Table 60. Siemens Business Overview

Table 61. Siemens LFA-based Cardiac Product

Table 62. Siemens Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 63. Siemens Recent Development

Table 64. Danaher Company Detail

Table 65. Danaher Business Overview

Table 66. Danaher LFA-based Cardiac Product

Table 67. Danaher Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 68. Danaher Recent Development

Table 69. Bio-Rad Laboratories Company Detail

Table 70. Bio-Rad Laboratories Business Overview

Table 71. Bio-Rad Laboratories LFA-based Cardiac Product

Table 72. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 73. Bio-Rad Laboratories Recent Development

Table 74. BioMérieux Company Detail

Table 75. BioMérieux Business Overview

Table 76. BioMérieux LFA-based Cardiac Product

Table 77. BioMérieux Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 78. BioMérieux Recent Development

Table 79. Thermo Fisher Company Detail

Table 80. Thermo Fisher Business Overview

Table 81. Thermo Fisher LFA-based Cardiac Product

Table 82. Thermo Fisher Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 83. Thermo Fisher Recent Development

Table 84. Ortho Clinical Diagnostics Company Detail

Table 85. Ortho Clinical Diagnostics Business Overview

Table 86. Ortho Clinical Diagnostics LFA-based Cardiac Product

Table 87. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 88. Ortho Clinical Diagnostics Recent Development

Table 89. LSI Medience Corporation Company Detail

Table 90. LSI Medience Corporation Business Overview

Table 91. LSI Medience Corporation LFA-based Cardiac Product

Table 92. LSI Medience Corporation Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 93. LSI Medience Corporation Recent Development

Table 94. Randox laboratories Company Detail

Table 95. Randox laboratories Business Overview

Table 96. Randox laboratories LFA-based Cardiac Product

Table 97. Randox laboratories Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 98. Randox laboratories Recent Development

Table 99. Wondfo Biotech Company Detail

Table 100. Wondfo Biotech Business Overview

Table 101. Wondfo Biotech LFA-based Cardiac Product

Table 102. Wondfo Biotech Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)

Table 103. Wondfo Biotech Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

List of Figures

Figure 1. Global LFA-based Cardiac Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global LFA-based Cardiac Market Share by Type: 2023 VS 2030

Figure 3. Troponin I Features

Figure 4. Troponin T Features

Figure 5. CK-MB Features

Figure 6. Myoglobin Features

Figure 7. Others Features

Figure 8. Global LFA-based Cardiac Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global LFA-based Cardiac Market Share by Application: 2023 VS 2030

Figure 10. Laboratory Testing Case Studies

Figure 11. Point-of-care Testing Case Studies

Figure 12. LFA-based Cardiac Report Years Considered

Figure 13. Global LFA-based Cardiac Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global LFA-based Cardiac Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global LFA-based Cardiac Market Share by Region: 2023 VS 2030

Figure 16. Global LFA-based Cardiac Market Share by Players in 2023

Figure 17. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by LFA-based Cardiac Revenue in 2023

Figure 19. North America LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America LFA-based Cardiac Market Share by Country (2019-2030)

Figure 21. United States LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe LFA-based Cardiac Market Share by Country (2019-2030)

Figure 25. Germany LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific LFA-based Cardiac Market Share by Region (2019-2030)

Figure 33. China LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America LFA-based Cardiac Market Share by Country (2019-2030)

Figure 41. Mexico LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa LFA-based Cardiac Market Share by Country (2019-2030)

Figure 45. Turkey LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 48. Abbott Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 49. Siemens Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 50. Danaher Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 51. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 52. BioMérieux Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 53. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 54. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 55. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 56. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 57. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Nocturia Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39M10215

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Medicine Treat BPH Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33F12613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Neurorehabilitation Gaming Systems Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E10017

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

Global Addison's Disease Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15W2944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions